Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial
07:00am, Thursday, 11'th Sep 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the Ameri
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Clinical Ophth
LAVAL, QC / ACCESS Newswire / September 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in the medical aest
Bausch (BHC) Up 21.4% Since Last Earnings Report: Can It Continue?
12:31pm, Friday, 29'th Aug 2025
Bausch (BHC) reported earnings 30 days ago. What's next for the stock?
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
08:00am, Tuesday, 26'th Aug 2025
LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX) t
LAVAL, QC / ACCESS Newswire / August 21, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced that
Bausch + Lomb board members resign after Icahn agreement ends
05:48pm, Monday, 18'th Aug 2025
Bausch + Lomb said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the termination of the agreement with billionaire Carl Icahn and some of his affiliates.
Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes
02:30pm, Friday, 15'th Aug 2025
LAVAL, QC / ACCESS Newswire / August 15, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced that Paulson Capital Inc. and certain affiliates and
Why Bausch Health Stock Surged By Nearly 20%
01:02pm, Tuesday, 12'th Aug 2025
Bausch Health surged by nearly 20% on high volume on Monday, rebounding from a post-earnings sell-off driven by high risk and debt concerns. Q2 results beat revenue and GAAP EPS estimates, with strong
Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners
08:00am, Thursday, 07'th Aug 2025
For the Sixth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 Scholarship LAVAL, QC / ACCESS Newswire / August 7, 2025 / Bausch Health Companies Inc. (NYSE:B
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat
11:50am, Thursday, 31'st Jul 2025
BHC stock falls 6.3% as Q2 earnings miss estimates despite stronger sales and growth in key segments like Salix and Solta Medical.
Bausch Health Companies Inc. (BHC) Q2 2025 Earnings Call Transcript
11:30pm, Wednesday, 30'th Jul 2025
Bausch Health Companies Inc. (NYSE:BHC ) Q2 2025 Earnings Conference Call July 30, 2025 5:00 PM ET Company Participants Garen Sarafian - VP & Head of Investor Relations Jean-Jacques Charhon - Executiv
Bausch (BHC) Reports Q2 Earnings: What Key Metrics Have to Say
10:01pm, Wednesday, 30'th Jul 2025
The headline numbers for Bausch (BHC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
Bausch Health (BHC) Lags Q2 Earnings Estimates
09:26pm, Wednesday, 30'th Jul 2025
Bausch Health (BHC) came out with quarterly earnings of $0.9 per share, missing the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $0.89 per share a year ago.
Bausch Health Announces Second Quarter 2025 Results
04:05pm, Wednesday, 30'th Jul 2025
Second Quarter Consolidated Revenues of $2.53 billion, up 5% on a Reported basis and 4% on an Organic (non-GAAP)1 basis over the prior year period GAAP Net Income Attributable to Bausch Health Compani
